Engela Helena Conradie

Engela Helena Conradie

Auto-generated profile, based on publicly available information

Engela Helena Conradie

Centre for Human Metabolomics, North-West University, Potchefstroom, South Africa

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2016 in Atmospheric Environment
Verified
Journal Article
Open access
ECE.H. Conradie
E.H. Conradie
PZPieter Van Zyl
Pieter Van Zyl
JPJ.J. Pienaar
J.J. Pienaar
PBPaul Johan Beukes
Paul Johan Beukes
CGCorinne Galy-Lacaux
Corinne Galy-Lacaux
GMG.V. Mkhatshwa
G.V. Mkhatshwa
South Africa is the economic hub of southern Africa and is regarded as an important source region of atmospheric pollutants. A nitrogen dioxide (NO2) hotspot is clearly visible from space over the South African Mpumalanga Highveld, while South Africa is also regarded as the 9th largest anthropogenic sulphur (S) emitting country. Notwithstanding the importance of South Africa with regard to nitrogen (N) and S emissions, very limited data has been published on the chemical composition of wet deposition for this region. This paper presents the concentrations of sodium (Na+), ammonium (NH4+), potassium (K+), calcium (Ca2+), magnesium (Mg2+), nitrate (NO3−), chloride (Cl−), sulphate (SO42−) and water-soluble organic acids (OA) in the wet deposition samples collected between 2009 and 2014 at four South African IDAF (IGAC DEBITS Africa) sites, which are regarded as regional representatives of the north-eastern interior. Also, wet deposition fluxes of the ten ions are calculated and presented in this paper. The results show that the total ionic concentrations and fluxes of wet deposition were much higher at the two sites closer to anthropogenic emissions, while the pH of wet deposition at these two sites were lower compared to that of the two sites that were less impacted by anthropogenic emissions. . The major sources of the ten ions included marine, terrigenous (crust), fossil fuel combustion, agriculture and biomass burning. Significant contributions from fossil fuel combustion were determined for the two sites in close proximity to anthropogenic source regions. The results of back trajectory analysis, however, did indicate that the two remote sites are also affected by air masses passing over the source region through anti-cyclonic recirculation. The largest contributions at the two sites distant from the anthropogenic source regions were marine sources, while the impact of biomass burning was also more significant at the remote sites. Comparison to previous wet deposition measurements at the South African IDAF sites indicated increases in the wet deposition fluxes of S and N, and more wet deposition events with lower pH. This could be ascribed to a significant increase in anthropogenic activities and population growth in this part of South Africa with an associated increase in energy demand

1 October 2025 in Biopreservation and Biobanking
Verified
Journal Article
Closed access
ECEngela Helena Conradie
Engela Helena Conradie
DADominique Elizabeth Anderson
Dominique Elizabeth Anderson
WFWarren Oswald Fransman
Warren Oswald Fransman
ASAlbe Carina Swanepoel
Albe Carina Swanepoel
MTMandile Samantha Thobela
Mandile Samantha Thobela
CSCarmen Swanepoel
Carmen Swanepoel
Biobanking is crucial for advancing medical research and personalized medicine, offering high-quality biospecimens for studies on biomarkers, drug development, and diagnostics. Despite its global potential, challenges such as fragmented governance and varying standards hinder biorepository collaboration, particularly in South Africa (SA). A unified national biobank network could enhance research and healthcare by improving biospecimen access, ethical governance, and collaboration. Global biobank networks offer models for standardization, data sharing, and international cooperation. SA can benefit from these models by creating a centralized biobank platform, promoting capacity building, and fostering regional and global partnerships. To address the challenges SA faces regarding biobanking, the Medical Biobanks Cluster established a network named Medical Biorepositories of SA (MBirSA), which seeks to build a cohesive network of medical biorepositories in SA. Through this network, it plans to foster an inclusive culture of biospecimen and data protocol harmonization, while encouraging adherence to legal, ethical, and quality best practices and standards. The network aims to bring stakeholders together, increasing visibility and transparency, and encouraging sector-wide collaboration. MBirSA also aims to offer training to build capacity in global best practices, aid in the development of dependable biorepository infrastructure, and promote research partnerships to enhance healthcare advancements.

11 October 2023 in Royal Society Open Science
Verified
Journal Article
Open access
Tozivepi Aaron MunyayiTozivepi Aaron Munyayi
Tozivepi Aaron Munyayi
DMDanielle Mulder
Danielle Mulder
ECEngela Helena Conradie
Engela Helena Conradie
BVBarend Christiaan Vorster
Barend Christiaan Vorster
Plasmonic colorimetric sensors have emerged as powerful analytical tools in biochemistry due to their localized surface plasmon resonance extinction in the visible range. Here, we describe the feasibility of NAD(P)/NAD(P)H as redox agents in enzymatic plasmonic gold nanostar (AuNS) assays for galactose quantification using three model enzymes, GalDH, AR and GalOx, immobilized separately on polyvinylpyrrolidone-capped AuNS scaffolds. These highly specific, sensitive and selective bioassays induce the transformation of AuNS into quasi-spherical nanoparticles during the biorecognition of galactose in water and synthetic blood matrices. As a result, using our inexpensive and simple AuNS plasmon bioassays, the presence of galactose may be detected spectrophotometrically and by the naked eye.

1 October 2025 in Biopreservation and Biobanking
Verified
Journal Article
Closed access
ECEngela H. Conradie
Engela H. Conradie
VAVarushka Acton
Varushka Acton
ASAlbe C. Swanepoel
Albe C. Swanepoel
Introduction: Rare disease research in South Africa (SA) faces significant challenges, including limited prioritization and awareness, which hinder advancements in patient care and scientific discovery. This article explores the recruitment strategies employed by the Centre for Human Metabolomics (CHM) Biobank, a nonhospital-based academic rare disease biobank, to address these challenges. Methods: We explain the consent process and documents as well as the three recruitment models employed, namely (1) Recruitment via referring clinician, (2) implementation of monthly diagnostic follow-up sessions, and (3) recruitment of patients for specific projects through clinic-based recruitment drives. Discussion: We discuss the benefits as well as the challenges of each model. Challenges included clinician and patient time constraints, distrust from current consent practices, and limited public awareness. We elaborate on future strategies to address these gaps such as simplifying consent, expanding recruitment sites, collaborating with clinical, academic and public institutions, and raising public awareness of the role of the CHM Biobank. Conclusions: From the models employed over the past 5 years, it is evident that recruitment is most effective when patients perceive a direct benefit, such as involvement in active projects. These strategies outlined in the discussion are crucial for ensuring the CHM Biobank’s sustainability, diversity, and its impact on scientific research and patient outcomes in SA.

5 February 2026 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
ASAlbe Carina Swanepoel
Albe Carina Swanepoel
CHChris Hendriksz
Chris Hendriksz
RMRenson Mukhwana
Renson Mukhwana
AOAbiola Oduwole
Abiola Oduwole
AAAsmahan T. Abdalla
Asmahan T. Abdalla
ECEngela Helena Conradie
Engela Helena Conradie
Background: Rare diseases (RDs) in Africa face challenges such as limited diagnosis, expertise, and treatment. FYMCA Medical Ltd., the International Gaucher Alliance (IGA) and the Centre for Human Metabolomics (CHM) at North‒West University (NWU) launched a pilot study in 2022 to create an African RD diagnosis network, focusing on training clinicians and testing dried blood spot (DBS) samples for 6 lysosomal storage disorders (LSDs). The pilot study spanned eight sub-Saharan African countries (Nigeria, Ghana, Tanzania, Kenya, Mozambique, Uganda, Botswana, and Sudan), with samples sent to South Africa for analysis. Clinician training at the CHM was well received, with positive feedback suggesting hybrid learning for future sessions. Results: The project registered 56 samples in 27 months; Gaucher disease was most common. MPS II was the most prevalent MPS condition, with a prevalence resembling Eastern hemisphere patterns. Genetic variants were consistent with previous studies, but Fabry diagnoses were rare, which indicates the need for more focused programs. Conclusions: The high diagnostic yield for LSDs highlights the importance of targeted training and DBS cards for genetic testing. Challenges included sample integrity, referral gaps, and logistical delays. Addressing these barriers and fostering ongoing clinician engagement will enhance diagnostic capacity, whereas presenting findings at an African symposium will increase awareness.